Advances in drug delivery systems utilizing blood cells and their membrane-derived microvesicles
The advancement of drug delivery systems (DDSs) in recent decades has demonstrated significant potential in enhancing the efficacy of pharmacological agents. Despite the approval of certain DDSs for clinical use, challenges such as rapid clearance from circulation, toxic accumulation in the body, an...
Saved in:
Main Authors: | Andong He (Author), Yuye Huang (Author), Chao Cao (Author), Xuejin Li (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood cells as supercarrier systems for advanced drug delivery
by: Shuo Wang, et al.
Published: (2022) -
The Effect of Mesenchymal Stem Cell-Derived Microvesicles on Erythroid Differentiation of Umbilical Cord Blood-Derived CD34+ Cells
by: Davod Pashoutan Sarvar, et al.
Published: (2018) -
Mesenchymal Stem Cell-Derived Microvesicles Support Ex Vivo Expansion of Cord Blood-Derived CD34+ Cells
by: Hui Xie, et al.
Published: (2016) -
Plant-Derived Nano and Microvesicles for Human Health and Therapeutic Potential in Nanomedicine
by: Mariaevelina Alfieri, et al.
Published: (2021) -
Multilayer Membranes of Glycosaminoglycans and Collagen I Biomaterials Modulate the Function and Microvesicle Release of Endothelial Progenitor Cells
by: Bingyan Dai, et al.
Published: (2016)